Provenance du réseau au premier degré de Sarah Lively
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California.
18
| Subsidiary | Investment Managers | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sarah Lively via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Founder | |
Azkarra Therapeutics, Inc.
 Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Azkarra Therapeutics, Inc. is a medical research and development company that specializes in providing oncology therapies based on DNA damage response. The company is based in South San Francisco, CA. Mohamad Tabrizi has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| IBM | Packaged Software | Corporate Officer/Principal Corporate Officer/Principal | |
| Brandeis University | College/University | Doctorate Degree Doctorate Degree | |
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA. | Biotechnology | Consultant / Advisor Director/Board Member | |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| IGNYTA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree | |
C2N Diagnostics LLC
 C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Biotechnology | Founder | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Adjuvant Partners LLC | Corporate Officer/Principal | ||
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| Indian Institute of Science | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Graduate Degree | |
| KINEMED INC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Scranton | College/University | Undergraduate Degree | |
| Drexel University | College/University | Graduate Degree | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| The University of Texas at Austin | College/University | Graduate Degree | |
| Golden Gate University School of Law | College/University | Graduate Degree | |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | General Counsel | |
| Hongsen Investment Management Ltd. | President | ||
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Consultant / Advisor | |
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ROYAL BANK OF CANADA | Major Banks | Corporate Officer/Principal | |
Aim-Hi Accelerator Fund, Inc.
 Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member | |
| Beijing University of Chemical Technology | College/University | Graduate Degree | |
Shangbay Capital Management Co. LLC
 Shangbay Capital Management Co. LLC Investment ManagersFinance Shangbay Capital Management Co. LLC (Shangbay Capital) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California. | Investment Managers | Consultant / Advisor | |
| University of New Hampshire | College/University | Undergraduate Degree | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| University of California, Davis | College/University | Undergraduate Degree | |
| SC Johnson College of Business | College/University | Masters Business Admin | |
Blue Oak Pharmaceuticals, Inc.
 Blue Oak Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Blue Oak Pharmaceuticals, Inc. is a therapeutics developer for brain disorders. Its research is in finding the next generation of drugs for the brain disorders to help patients by creating new medicines, transform the CNS drug discovery paradigm, and achieve rapid clinical neurobiology measures and translational biomarkers. The company was founded by Thomas H. Large and Kerry L. Spear in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 43 |
| Chine | 5 |
| Inde | 3 |
| Hong Kong | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 17 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 29 |
| Consultant / Advisor | 22 |
| Director/Board Member | 19 |
| Undergraduate Degree | 12 |
| Doctorate Degree | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xin Hui | 14 |
| Peter DiLaura | 13 |
| Ya Jun Xu | 12 |
| Ravi Kiron | 11 |
| David Spellmeyer | 11 |
| Mohamad Tabrizi | 10 |
| Robert A. Drakas | 9 |
| Grant Green | 8 |
| Dirk Brockstedt | 7 |
| Stephen Munk | 6 |
| Robert Wild | 6 |
| Krishna Kodukula | 5 |
| Robert Lutz | 4 |
| Jean Bidegainberry | 1 |
| Juan-Carlos Lopez | 1 |
- Bourse
- Insiders
- Sarah Lively
- Connexions Sociétés
